Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Neurophysiol ; 69(6): 2056-71, 1993 Jun.
Article in English | MEDLINE | ID: mdl-7688800

ABSTRACT

1. Outward currents in identified cell types from the pyloric system of the stomatogastric ganglion (STG) of the spiny lobster, Panulirus marginatus, were studied under two-microelectrode voltage clamp. A comparison was made between data from intact cells and somata isolated by ligation of the primary neurite of these monopolar neurons. 2. Despite the elimination of current contributions from the extensive arborizations of STG neurons, few significant differences were found in the mean values of parameters for outward currents between populations of isolated somata and intact cells of a given type. Measurements that showed little difference included magnitude and activation threshold of a calcium-dependent outward current (IJ) and magnitude, activation threshold, voltage dependence, and inactivation time course of A current (IA). Although previous work has suggested that IJ might reside predominantly in the soma, IA is known to be distributed in poorly space-clamped neurite processes. The absence of obvious effects of isolation was thus unexpected. 3. To better understand the mechanisms involved, we used compartmental models derived from reconstructed neurons to simulate the effects of isolation. It was concluded that, for the particular conditions present in stomatogastric neurons, with a large, uniformly distributed outward current conductance activated, even though neurites and axon remain attached, most measured current flows through well-clamped soma membrane. 4. Factors contributing to this result included the outward sign of the current, the large specific conductance activated in these neurons (among the larger reported in somata), and the presence of only a single major process leaving the soma. The potential for serious errors in voltage-clamp measurements from intact cells remains if these conditions are not met.


Subject(s)
Ion Channels/physiology , Motor Neurons/physiology , Nephropidae/physiology , Stomach/innervation , Animals , Calcium/physiology , Computer Simulation , Electrophysiology , Female , Ganglia/cytology , Ganglia/physiology , In Vitro Techniques , Kinetics , Male , Membrane Potentials/physiology , Microelectrodes , Models, Neurological , Neurites/physiology , Pylorus/innervation
2.
N Z Vet J ; 33(6): 94-7, 1985 Jun.
Article in English | MEDLINE | ID: mdl-16031173

ABSTRACT

Primary hypoparathyroidism was diagnosed in three St. Bernard bitches. Anorexia, behavioural changes, muscle tremors, seizures, panting respiration, and cataracts were the clinical signs observed. The serum concentration of calcium was low, the phosphorus concentration elevated, and the immunoreactive parathyroid hormone level low in all dogs. The aetiology of the hypoparathyroidism was not determined in any of the dogs. Treatment with synthetic vitamin D (1,25-dihydroxycholecalciferol) and an oral calcium supplement was successful in restoring and then maintaining a normal concentration of serum calcium in two of the dogs.

4.
J Gen Virol ; 36(1): 199-202, 1977 Jul.
Article in English | MEDLINE | ID: mdl-196039

ABSTRACT

The multiple microtrephination technique was used in the rabbit cornea to compare the activity against herpes simplex virus (hsv) of adenine arabinoside (ara-A), ara-A 5'monophosphate (ara-AMP) and hypoxanthine arabinoside (ara-Hx), and to determine the effect of addition of adenosine deaminase inhibitor (ADAI) to each. The greatest antiviral activity was shown by ara-AMP, and the least by ara-Hx. ADAI increased the activity of ara-A but had no effect on ara-AMP or ara-Hx.


Subject(s)
Adenosine Deaminase Inhibitors , Antiviral Agents/therapeutic use , Enzyme Inhibitors/therapeutic use , Keratitis, Dendritic/drug therapy , Nucleoside Deaminases/antagonists & inhibitors , Vidarabine/analogs & derivatives , Vidarabine/therapeutic use , Animals , Cornea/microbiology , Drug Evaluation, Preclinical , Drug Therapy, Combination , Ointments , Rabbits , Simplexvirus/drug effects , Simplexvirus/growth & development , Virus Replication/drug effects
5.
Br J Ophthalmol ; 61(4): 255-9, 1977 Apr.
Article in English | MEDLINE | ID: mdl-322700

ABSTRACT

An open trial was carried out on 63 patients in London to assess the efficacy of 1% rifampicin eye ointment in comparison with 1% chloramphenicol eye ointment in the treatment of sexually transmitted TRIC infection of the eye. Patients included were selected on the basis of positive cultures for Chlamydia trachomatis. Three weeks' treatment with rifampicin eye ointment used 3 times daily was not sufficient to cure the disease, but a 6 or 7 week course gave 90% clinical and microbiological cure rate. Treatment with chloramphenicol eye ointment 3 times daily for 4 to 6 weeks failed to cure the disease.


Subject(s)
Chloramphenicol/therapeutic use , Rifampin/therapeutic use , Sexually Transmitted Diseases/drug therapy , Trachoma/drug therapy , Adult , Clinical Trials as Topic , Conjunctivitis/chemically induced , Female , Humans , Infant, Newborn , Male , Middle Aged , Rifampin/adverse effects
7.
Am J Ophthalmol ; 79(6): 941-8, 1975 Jun.
Article in English | MEDLINE | ID: mdl-166561

ABSTRACT

We used the photodynamic inactivation technique with proflavine as the photoactive dye to treat herpetic epithelial keratitis in a preliminary study of patients who had idoxuridine toxicity or resistance. A comparative study with idoxuridine in treating dendritic ulcerations of the cornea showed a good therapeutic effect. But the investigation was suspended when adverse reactions, consisting of a generalized epithelial keratitis and an anterior uveitis, possibly of phototoxic origin, developed in a few patients receiving treatment. The ulcers treated by photodynamic inactivation apparently healed by a process of "debridement" followed by subsequent re-epithelialization.


Subject(s)
Acridines/therapeutic use , Keratitis, Dendritic/drug therapy , Phototherapy , Proflavine/therapeutic use , Adult , Anterior Chamber , Betamethasone/therapeutic use , Edema/etiology , Female , Humans , Idoxuridine/therapeutic use , Idoxuridine/toxicity , Male , Middle Aged , Prednisolone/therapeutic use , Prednisone/therapeutic use , Proflavine/adverse effects , Proflavine/pharmacology , Recurrence , Simplexvirus/drug effects , Suppuration/etiology , Wound Healing
8.
Am J Ophthalmol ; 79(5): 719-51, 1975 May.
Article in English | MEDLINE | ID: mdl-1096622

ABSTRACT

Effective antifungal therapy must be long-term, nondamaging, penetrating to the eye, and highly active against each patient's fungus. Results of antifungal sensitivity testing of 61 collected ocular fungal pathogens and observations in 25 cases treated with one of the nonpolyene antifungal drugs indicated that infection was rapidly controlled and eradicated with restoration of visual acuity, determined by the degree of disorganization present at the time of commencement of rational specific antifungal therapy. Pimaricin has the widest spectrum, a medium level of activity, and rather poor penetration but is recommended as an antifungal prophylactic and as first-line-therapy for ocular fungal disease while awaiting identification and sensitivity testing of the fungus. Flucytosine combined with amphotericin B, or possibly with clotrimazole or miconazole, is recommended for Candida infections. Clotrimazole is the drug of choice for Aspergillus species although miconazole and econazole are more effective with some isolates. Miconazole and econazole are recommended for miscellaneous filamentous fungi although clotrimazole or thiabendazole are superior in some cases. Each of these drugs may be useful in patients infected with Fusarium who do not respond to primaricin. In these cases, drug use should be guided by the results of antifungal sensitivity testing. In addition to medical antifungal therapy some eyes may require excisional keratoplasty with the lens removal and evacuation of the posterior chamber and anterior vitreous cavity.


Subject(s)
Antifungal Agents/therapeutic use , Eye Diseases/drug therapy , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Amphotericin B/therapeutic use , Animals , Aspergillosis/drug therapy , Aspergillus/drug effects , Blindness/etiology , Candida/drug effects , Candidiasis/drug therapy , Clotrimazole/therapeutic use , Cornea , Eye Diseases/complications , Eye Diseases/etiology , Female , Fusarium/drug effects , Glaucoma/etiology , Glaucoma/microbiology , Humans , Imidazoles/therapeutic use , Male , Middle Aged , Mycoses/complications , Mycoses/drug therapy , Natamycin/therapeutic use , Polyenes/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL